Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neoplasms | D009369 | — | C80 | 4 | — | — | — | — | 4 |
Glioblastoma | D005909 | EFO_0000515 | — | 2 | — | — | — | — | 2 |
Lymphoma | D008223 | — | C85.9 | 2 | — | — | — | — | 2 |
Astrocytoma | D001254 | EFO_0000271 | — | 1 | — | — | — | — | 1 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | 1 | — | — | — | — | 1 |
Brain neoplasms | D001932 | EFO_0003833 | C71 | 1 | — | — | — | — | 1 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 1 | — | — | — | — | 1 |
Second primary neoplasms | D016609 | — | — | 1 | — | — | — | — | 1 |
Drug common name | TROTABRESIB |
INN | trotabresib |
Description | Trotabresib is a small molecule pharmaceutical. It is currently being investigated in clinical studies. |
Classification | Small molecule |
Drug class | extra-terminal motif (BET) family of bromodomain (BRD) proteins |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | Cn1cc(-c2cc(S(C)(=O)=O)ccc2OCC2CC2)c2ccccc2c1=O |
PDB | — |
CAS-ID | 1706738-98-8 |
RxCUI | — |
ChEMBL ID | CHEMBL4650366 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | K424WH3WU0 (ChemIDplus, GSRS) |